市場調査レポート

商品コード

1519360

シングルユースバイオリアクター市場レポート：製品タイプ、タイプ、細胞タイプ、分子タイプ、エンドユーザー、地域別、2024年～2032年

Single-Use Bioreactors Market Report by Product Type, Type, Cell Type, Molecule Type, End User, and Region 2024-2032

出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 431,945円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,999 575,975円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 720,005円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.03円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のシングルユースバイオリアクター市場規模は2023年に34億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに111億米ドルに達し、2024年から2032年の間に13.8％の成長率（CAGR）を示すと予測しています。同市場は、バイオ医薬品の需要増加、同製品が提供するコスト効率と拡張性、シングルユース技術の著しい市場開拓、製造受託機関（CMO）における同製品の採用増加、細胞治療および遺伝子治療生産における使用量の増加によって推進されています。

シングルユースバイオリアクター市場分析：

主な市場促進要因主な市場促進要因：バイオ医薬品需要の増加、製品が提供するコスト効率と拡張性、シングルユース技術の著しい発展などが主な市場促進要因として挙げられます。

主な市場動向：製造受託機関（CMO）における製品採用の増加、細胞・遺伝子治療製造における利用の増加、バイオリアクター設計の大幅な進歩などが、シングルユース・バイオリアクターの主な市場動向です。

地理的動向：バイオ医薬品の使用量の増加、バイオプロセス技術への投資の増加、従来のスチール製バイオリアクターよりもシングルユースシステムの利点が高まっていることから、北米が市場を独占しています。

競合情勢：ABEC Inc.、Cellexus、Celltainer Biotech B.V.、CESCO Bioengineering Co.Ltd.、Distek Inc.、Eppendorf SE、General Electric Company、Getinge AB、Merck KGaA、Pall Corporation（Danaher Corporation）、PBS Biotech Inc.、Sartorius AG、Thermo Fisher Scientific Inc.などがシングルユース・バイオリアクター業界の主要企業です。

課題と機会：業界の課題としては、製品の初期コストの高さやプラスチック廃棄物に関する懸念の高まりなどが挙げられます。一方、市場開拓の機会としては、シングルバイオリアクターの設計における著しい技術開発、個別化医療や少量生産に対する需要の高まりなどが挙げられます。

シングルユースバイオリアクター市場傾向：

バイオ医薬品の採用増加

バイオ医薬品業界は、糖尿病、がん、自己免疫疾患などの慢性疾患を含む数多くの疾患に対する新しく効果的な治療に対する需要の高まりにより、急速に成長しています。IMARC GROUPによると、世界のバイオ医薬品市場は2023年に3,005億米ドルに達し、2032年には6,439億米ドルに達すると予想され、2024-2032年のCAGRは8.6%です。ワクチン、モノクローナル抗体、組換えタンパク質を含むバイオ医薬品は、生きた細胞を用いて生産されるため、高度に特殊な生産環境が必要とされます。シングルユース・バイオリアクター（SUB）は、そのコスト効率、柔軟性、交差汚染のリスク低減の点で、非常に採用されています。SUBは製品開発と生産にかかる時間を短縮できるため、バイオ医薬品企業はこうした需要に迅速に対応し、患者のための新しい治療法を開発することができます。

バイオプロセス技術への投資の増加

バイオプロセス技術への投資が増加しているのは、生産能力を向上させ、業務効率を高めようとしているためです。IMARC GROUPが発表したレポートによると、世界のバイオプロセス技術市場は2023年に292億米ドルに達し、2032年には533億米ドルに達すると予想され、2024年から2032年のCAGRは6.93%です。シングルユース・バイオリアクターは、資本支出の削減、洗浄やバリデーションの必要性の最小化、生産量の増減における柔軟性の向上など、さまざまなメリットを提供することで、バイオプロセスのワークフローを整理することができます。主要企業は、生産プロセスを最大化し、ダウンタイムを最小化し、コスト効率を達成するために、シングルユース技術に幅広く投資しています。

有利な規制支援と有利な政府政策

規制当局や政府機関は、製品の安全性、有効性、品質を保証するガイドラインや枠組みを永続させることで、バイオ医薬品製造の情勢を進化させる上で大きな役割を果たしています。近年、シングルユース・バイオリアクター（SUB）の利点が規制当局の間で認識されつつあります。米国食品医薬品局（FDA）や欧州医薬品庁（EMA）などの規制機関は、汚染リスクを低減し、プロセス効率を向上させるシングルユース技術を支持してきました。このような規制当局の支援は、SUBの採用に好都合な環境を提供し、バイオ医薬品企業にこれらのシステムへの投資を促しています。

北米
- 米国
- カナダ
アジア太平洋
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測

第12章 SWOT分析

概要
強み
弱み
機会
脅威

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第15章価格分析

第16章競合情勢

市場構造
主要企業
主要企業のプロファイル
- ABEC Inc.
- Cellexus
- Celltainer Biotech B.V.
- CESCO Bioengineering Co. Ltd.
- Distek Inc.
- Eppendorf SE
- General Electric Company
- Getinge AB
- Merck KGaA
- Pall Corporation（Danaher Corporation）
- PBS Biotech Inc.
- Sartorius AG
- Thermo Fisher Scientific Inc.

図表

List of Figures

Figure 1: Global: Single-use Bioreactor Market: Major Drivers and Challenges
Figure 2: Global: Single-use Bioreactor Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Single-use Bioreactor Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Single-use Bioreactor Market: Breakup by Product Type (in %), 2023
Figure 5: Global: Single-use Bioreactor Market: Breakup by Type (in %), 2023
Figure 6: Global: Single-use Bioreactor Market: Breakup by Cell Type (in %), 2023
Figure 7: Global: Single-use Bioreactor Market: Breakup by Molecule Type (in %), 2023
Figure 8: Global: Single-use Bioreactor Market: Breakup by End User (in %), 2023
Figure 9: Global: Single-use Bioreactor Market: Breakup by Region (in %), 2023
Figure 10: Global: Single-use Bioreactor (Single-use Bioreactor Systems) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Single-use Bioreactor (Single-use Bioreactor Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Single-use Bioreactor (Media Bags) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Single-use Bioreactor (Media Bags) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Single-use Bioreactor (Filtration Assemblies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Single-use Bioreactor (Filtration Assemblies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Single-use Bioreactor (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Single-use Bioreactor (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Single-use Bioreactor (Stirred-tank Bioreactors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Single-use Bioreactor (Stirred-tank Bioreactors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Single-use Bioreactor (Wave-induced Bioreactors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Single-use Bioreactor (Wave-induced Bioreactors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Single-use Bioreactor (Bubble-column Bioreactors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Single-use Bioreactor (Bubble-column Bioreactors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Single-use Bioreactor (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Single-use Bioreactor (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Single-use Bioreactor (Mammalian Cells) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Single-use Bioreactor (Mammalian Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Single-use Bioreactor (Bacteria) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Single-use Bioreactor (Bacteria) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Single-use Bioreactor (Yeast) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Single-use Bioreactor (Yeast) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Single-use Bioreactor (Other Cell Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Single-use Bioreactor (Other Cell Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Single-use Bioreactor (Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Single-use Bioreactor (Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Single-use Bioreactor (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Single-use Bioreactor (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Single-use Bioreactor (Stem Cells) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Single-use Bioreactor (Stem Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Single-use Bioreactor (Recombinant Proteins) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Single-use Bioreactor (Recombinant Proteins) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: Single-use Bioreactor (Other Molecule Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: Single-use Bioreactor (Other Molecule Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Global: Single-use Bioreactor (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Global: Single-use Bioreactor (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Global: Single-use Bioreactor (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Global: Single-use Bioreactor (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Global: Single-use Bioreactor (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Global: Single-use Bioreactor (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Global: Single-use Bioreactor (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Global: Single-use Bioreactor (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: North America: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: North America: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: United States: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: United States: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Canada: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Canada: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Asia-Pacific: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Asia-Pacific: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: China: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: China: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Japan: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Japan: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: India: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: India: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: South Korea: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: South Korea: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Australia: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Australia: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Indonesia: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Indonesia: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Europe: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Europe: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Germany: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Germany: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: France: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: France: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: United Kingdom: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: United Kingdom: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Italy: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Italy: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Spain: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Spain: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Russia: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Russia: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Others: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: Others: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Latin America: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: Latin America: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 92: Brazil: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 93: Brazil: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 94: Mexico: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 95: Mexico: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 96: Others: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
Figure 97: Others: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032

Figure 98 Middle East and Africa: Single-use Bioreactor Market: Sales Value (in Million US$), 2018 & 2023

Figure 99: Middle East and Africa: Single-use Bioreactor Market: Breakup by Country (in %), 2023
Figure 100: Middle East and Africa: Single-use Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 101: Global: Single-use Bioreactor Industry: SWOT Analysis
Figure 102: Global: Single-use Bioreactor Industry: Value Chain Analysis
Figure 103: Global: Single-use Bioreactor Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Single-use Bioreactor Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Single-use Bioreactor Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 3: Global: Single-use Bioreactor Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 4: Global: Single-use Bioreactor Market Forecast: Breakup by Cell Type (in Million US$), 2024-2032
Table 5: Global: Single-use Bioreactor Market Forecast: Breakup by Molecule Type (in Million US$), 2024-2032
Table 6: Global: Single-use Bioreactor Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 7: Global: Single-use Bioreactor Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Single-use Bioreactor Market: Competitive Structure
Table 9: Global: Single-use Bioreactor Market: Key Players

Product Code: SR112024A5151

The global single-use bioreactors market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.1 Billion by 2032, exhibiting a growth rate (CAGR) of 13.8% during 2024-2032. The market is propelled by the increasing demand for biopharmaceuticals, cost-efficiency and scalability offered by the product, significant developments in single-use technology, increasing product adoption in contract manufacturing organizations (CMOs), rising usage in cell and gene therapy production.

Single-Use Bioreactors Market Analysis:

Major Market Drivers: Increasing demand for biopharmaceuticals, cost-efficiency and scalability offered by the product, and significant developments in single-use technology are some of the major market drivers.

Key Market Trends: Growing product adoption in contract manufacturing organizations (CMOs), increasing utilization in cell and gene therapy productions, and significant advancements in bioreactor design are some single-use bioreactors key market trends.

Geographical Trends: North America dominates the market on account of the increasing usage of biopharmaceuticals, rising investment in bioprocessing technologies, and growing benefits of single-use systems more than conventional-steel bioreactors.

Competitive Landscape: ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc., are among some of the key players in the single-use bioreactors industry.

Challenges and Opportunities: Some of the challenges of the industry include high initial product costs and increasing concerns about plastic waste. Whereas, opportunities of the market include the significant technological developments in single-bioreactor designs and the rising demand for personalized medicine and small-batch production.

Single-Use Bioreactors Market Trends:

Rising Adoption of Biopharmaceuticals

The biopharmaceutical industry is rapidly growing on account of the increasing demand for new and effective treatments for numerous diseases, including chronic diseases, such as diabetes, cancer, and autoimmune disorders. According to the IMARC GROUP, the global biopharmaceuticals market has reached US$ 300.5 Billion in 2023, and is expected to reach US$ 643.9 Billion by 2032, exhibiting a CAGR of 8.6% during 2024-2032. Biopharmaceuticals which possess vaccines, monoclonal antibodies, and recombinant proteins, are produced using living cells, which need highly specialized production environments. Single-use bioreactors (SUBs) are highly adopted on account of their cost-efficiency, flexibility, and reduced risk of cross-contamination. They allow quicker product development and production times, thus enabling biopharmaceutical companies to rapidly cater to these demands and develop new therapies for patients.

Rising Investment in Bioprocessing Technologies

The rising investment in bioprocessing technologies is increasing as they seek to improve their production capabilities and enhance operational efficiencies. As per a report published by the IMARC GROUP, the global bioprocess technology market has reached US$ 29.2 Billion in 2023, and is expected to reach US$ 53.3 Billion by 2032, exhibiting a CAGR of 6.93% during 2024-2032. Single-use bioreactors are able to organize the bioprocessing workflow by offering a wide variety of benefits such as reduced capital expenditure, minimized cleaning and validation requirements, and better flexibility in scaling up or down production volumes. Key players are extensively investing in single-use technologies to maximize their production processes, minimize downtime, and achieve cost-efficiency.

Favorable Regulatory Support and Favorable Government Policies

Regulatory agencies and government bodies play a major role in evolving the landscape of biopharmaceutical manufacturing by enduring guidelines and frameworks that guarantee product safety, efficacy, and quality. In recent years, there has been a growing recognition of the benefits of single-use bioreactors (SUBs) within the regulatory community. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have been supportive of single-use technologies due to their ability to reduce contamination risks and improve process efficiencies. This regulatory support has provided a conducive environment for the adoption of SUBs, encouraging biopharmaceutical companies to invest in these systems.

Single-Use Bioreactors Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, type, cell type, molecule type, and end user.

Breakup by Product Type:

Single-use Bioreactor Systems

Media Bags

Filtration Assemblies

Others

Single-use bioreactor systems accounts for the majority of the market share

The single-use bioreactors market report has provided a detailed breakup and analysis of the market based on the product type. This includes single-use bioreactor systems, media bags, filtration assemblies, and others. According to the report, single-use bioreactor systems represented the largest segment.

Single-use bioreactor systems dominate the market on account of the numerous benefits offered by them. These are meant for single time usage, which eliminates the need of the vigorous cleaning and sterilization procedure that stainless-steel bioreactors need. This in turn minimizes the downtime between production runs, improves operational efficiency, and reduces the risk of cross-contamination, which is vital in biopharmaceutical production.

Breakup by Type:

Stirred-tank Bioreactors

Wave-induced Bioreactors

Bubble-column Bioreactors

Others

Stirred tank bioreactors holds the largest share in the industry

A detailed breakup and analysis of the market based on the type have also been provided in the report. This includes stirred-tank bioreactors, wave-induced bioreactors, bubble-column bioreactors, and others. According to the report, stirred tank bioreactors accounted for the largest market share.

Stirred tank bioreactors hold maximum number of single-use bioreactors market share on account of their efficiency, scalability, and versatility in a wide variety of bioprocessing applications. These bioreactors are built to offer optimized mixing and aeration conditions, which are vital for maintaining uniform cell culture environments and achieving high cell densities and product results. This type of single-use bioreactors is appropriate for both microbial and mammalian cell cultures, thereby making it a preferred choice for creating a wide variety of biopharmaceutical products, such as vaccines, monoclonal antibodies, and recombinant proteins.

Breakup by Cell Type:

Mammalian Cell

Bacteria

Yeast

Others

Mammalian cell represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the cell type. This includes mammalian cell, bacteria, yeast, and others. According to the report, mammalian cell represented the largest segment.

Mammalian cells hold the largest market share due to several critical factors. Initially, mammalian cells are critical for producing complex biopharmaceuticals such as monoclonal antibodies, recombinant proteins, and vaccines. These therapeutic agents need mammalian cells for their post-translational modifications, which are crucial for their functional and structural integrity. Unlike microbial or yeast cells, mammalian cells can perform glycosylation and other modifications that are vital for the efficacy and safety of biopharmaceutical products. Mammalian cells possess the ability to produce human-like glycosylation patterns which further makes them irreplaceable for the development of biologics that need to mimic natural human proteins closely.

Breakup by Molecule Type:

Vaccines

Monoclonal Antibodies

Stem Cells

Recombinant Proteins

Others

Vaccines exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the molecule type have also been provided in the report. This includes vaccines, monoclonal antibodies, stem cells, recombinant proteins, and others. According to the report, vaccines accounted for the largest market share.

Vaccines represent the largest segment due to several compelling factors, such as the rising global demand for vaccines, driven by the continuous upsurge of infectious diseases and the need for rapid and effective immunization strategies. The COVID-19 pandemic is a notable instance that has underlined the importance of vaccines, promoting unprecedented investments in vaccine research, development, and production. Single-use bioreactors have become indispensable in this context because of their flexibility, scalability, and ability to support quick production cycles, which are critical for meeting urgent vaccine demands.

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Contract Research Organizations

Academic and Research Institutes

Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes pharmaceutical and biopharmaceutical companies, contract research organizations, academic and research institutes, and others.

Pharmaceutical and biopharmaceutical companies are the primary end users of single-use bioreactors. These organizations leverage single-use systems for the production of a wide range of therapeutics, including monoclonal antibodies, recombinant proteins, and, notably, vaccines.

Contract Research Organizations (CROs) are significant users of single-use bioreactors, offering outsourced research services to pharmaceutical and biopharmaceutical companies. CROs utilize these systems to conduct various stages of drug development, including preclinical and clinical research.

Academic and research institutes play a crucial role in the innovation and development of new bioprocessing technologies. These institutions use single-use bioreactors for experimental and educational purposes, focusing on the research and development of new drugs, vaccines, and therapeutic proteins.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest single-use bioreactors market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is the largest segment in the single-use bioreactors market by region due to several key factors. The region is home to a robust biopharmaceutical industry with significant investment in research and development. The presence of major pharmaceutical and biotechnology companies, coupled with a strong focus on innovation and advanced manufacturing technologies, drives the demand for single-use bioreactors. Additionally, North America benefits from well-established regulatory frameworks and government support for biopharmaceutical production, particularly in response to public health challenges such as the COVID-19 pandemic.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the single use bioreactors industry include ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players in the single-use bioreactors industry have undertaken several strategic efforts to drive market growth and innovation. Companies such as Thermo Fisher Scientific, Sartorius Stedim Biotech, and GE Healthcare are at the forefront of these initiatives. One major area of focus has been the continuous enhancement of product portfolios through research and development. These companies invest heavily in developing new and improved bioreactor designs that offer greater efficiency, scalability, and ease of use. Innovations such as automated control systems, improved sensors, and better materials for bioreactor components are some of the advancements being pursued.

Latest News:

March 2023: MARQMETRIX launched its latest "SINGLE-USE BIOREACTOR BALL PROVE". This technology reduces the danger of contamination while increasing productivity and lowering expanses.

March 2023: DISTEK launched the latest edition to the BIOne product line, the BIOne 10L Single-Use Bioreactor (SUB).

Key Questions Answered in This Report

1. What was the size of the global single-use bioreactors market in 2023?
2. What is the expected growth rate of the global single-use bioreactors market during 2024-2032?
3. What are the key factors driving the global single-use bioreactors market?
4. What has been the impact of COVID-19 on the global single-use bioreactors market?
5. What is the breakup of the global single-use bioreactors market based on the product type?
6. What is the breakup of the global single-use bioreactors market based on the type?
7. What is the breakup of the global single-use bioreactors market based on the cell type?
8. What is the breakup of the global single-use bioreactors market based on the molecule type?
9. What are the key regions in the global single-use bioreactors market?
10. Who are the key players/companies in the global single-use bioreactors market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Single-use Bioreactor Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Single-use Bioreactor Systems
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Media Bags
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Filtration Assemblies
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Type

7.1 Stirred-tank Bioreactors
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Wave-induced Bioreactors
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Bubble-column Bioreactors
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Cell Type

8.1 Mammalian Cells
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Bacteria
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Yeast
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Molecule Type

9.1 Vaccines
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Monoclonal Antibodies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Stem Cells
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Recombinant Proteins
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast

10 Market Breakup by End User

10.1 Pharmaceutical and Biopharmaceutical Companies
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Contract Research Organizations
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Academic and Research Institutes
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
10.4 Others
- 10.4.1 Market Trends
- 10.4.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia-Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 ABEC Inc.
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
- 16.3.2 Cellexus
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
- 16.3.3 Celltainer Biotech B.V.
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
- 16.3.4 CESCO Bioengineering Co. Ltd.
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
- 16.3.5 Distek Inc.
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
- 16.3.6 Eppendorf SE
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
  - 16.3.6.3 SWOT Analysis
- 16.3.7 General Electric Company
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
  - 16.3.7.3 Financials
  - 16.3.7.4 SWOT Analysis
- 16.3.8 Getinge AB
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis
- 16.3.9 Merck KGaA
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
  - 16.3.9.3 Financials
  - 16.3.9.4 SWOT Analysis
- 16.3.10 Pall Corporation (Danaher Corporation)
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 SWOT Analysis
- 16.3.11 PBS Biotech Inc.
  - 16.3.11.1 Company Overview
  - 16.3.11.2 Product Portfolio
- 16.3.12 Sartorius AG
  - 16.3.12.1 Company Overview
  - 16.3.12.2 Product Portfolio
  - 16.3.12.3 Financials
  - 16.3.12.4 SWOT Analysis
- 16.3.13 Thermo Fisher Scientific Inc.
  - 16.3.13.1 Company Overview
  - 16.3.13.2 Product Portfolio
  - 16.3.13.3 Financials
  - 16.3.13.4 SWOT Analysis

シングルユースバイオリアクター市場レポート：製品タイプ、タイプ、細胞タイプ、分子タイプ、エンドユーザー、地域別、2024年～2032年

Single-Use Bioreactors Market Report by Product Type, Type, Cell Type, Molecule Type, End User, and Region 2024-2032

シングルユースバイオリアクター市場分析：

シングルユースバイオリアクター市場傾向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界使い捨てバイオリアクター市場

第6章 市場内訳：製品タイプ別

第7章 市場内訳：タイプ別

第8章 市場内訳：細胞タイプ別

第9章 市場内訳：分子タイプ別

第10章 市場内訳：エンドユーザー別

第11章 市場内訳：地域別

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 価格分析

第16章 競合情勢

List of Figures

List of Tables

Single-Use Bioreactors Market Analysis:

Single-Use Bioreactors Market Trends:

Single-Use Bioreactors Industry Segmentation:

Breakup by Product Type:

Breakup by Type:

Breakup by Cell Type:

Breakup by Molecule Type:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

Latest News:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Single-use Bioreactor Market

6 Market Breakup by Product Type

7 Market Breakup by Type

8 Market Breakup by Cell Type

9 Market Breakup by Molecule Type

10 Market Breakup by End User

11 Market Breakup by Region

12 SWOT Analysis

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Price Analysis

16 Competitive Landscape

第1章序文

第2章調査範囲と調査手法

第3章エグゼクティブサマリー

第4章イントロダクション

第5章世界使い捨てバイオリアクター市場

第6章市場内訳：製品タイプ別

第7章市場内訳：タイプ別

第8章市場内訳：細胞タイプ別

第9章市場内訳：分子タイプ別

第10章市場内訳：エンドユーザー別

第11章市場内訳：地域別

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

第15章価格分析

第16章競合情勢